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vascular closure device to improve hemostasis
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The Perclose ProGlide (Abbott Vascular, Santa Clara, Calif) is indicated for the closure of 5F to 21F femoral artery access
sites. We describe an adjunctive technique for the use of the ProGlide vascular closure device to improve hemostasis. After
routine use of the device, a hollow tube (cut from the injection port of an introducer sheath) is placed over the free tails of
suture. These tubes are secured in place by a hemostat that grasps the free suture tails, creating a Rummel-style tourniquet
that compresses the arteriotomy, improving hemostasis. The tubes doubly serve as a conduit for the administration of
prothrombotic agents directly in the event that hemostasis is not adequately achieved. (J Vasc Surg 2014;60:1693-4.)The Perclose ProGlide (Abbott Vascular, Santa Clara,
Calif) vascular closuredevice is indicated for the percutaneous
delivery of suture for closure of the common femoral artery
access site in patients undergoingdiagnostic or interventional
catheterizationprocedures that use5F to21F sheaths, per the
instructions for use.1 The use of the closure device is associ-
ated with reduced procedure times, increased comfort of
the patient, and shorter time to ambulation after interven-
tion. The Perclose ProGlide functions by supplying a mono-
ﬁlament polypropylene suture for closure of the arteriotomy
site. Even with appropriate use of this device, a subset of pa-
tients may continue to have active bleeding and require con-
version to open repair. We describe an adjunctive technique
with the use of this device that can improve hemostasis.
TECHNIQUE
The Committee for the Protection of Human Subjects,
the local Institutional Review Board, approved this study
with a waiver of consent. The ProGlide device deployment
sequence has been previously described.1,2 The ProGlide is
advanced over a guidewire within the arterial lumen, after
which the “feet” are deployedwithin the lumen to abut the ar-
tery wall and temporarily occlude the vessel. The plunger is
then depressed to deploy twoneedleswithin the subcutaneous
tissue. Further depression of the plunger advances the needles
through feet inside the lumen, thus forming a loop of suture.the Department of Cardiothoracic and Vascular Surgery, University of
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a whole, leaving behind two suture tails. The ProGlide is
used for 5F to 8F sheath procedures; for sheaths between 8F
and 18F, two closure devices are often used. The large sheath
used for access is removed over thewire. The site is then closed
in standard fashion by using the knot pusher on the blue
threads. The wire is then removed, and the knot is set by
retracting on the white threads. The transparent tubing from
the injection port of the 5F sheath is then cut off. The tube is
then cut in half. The two free ends of suture are then threaded
through the cut tubes and grasped with a hemostat at the end
farthest from the vessel (Fig 1). A Rummel-style tourniquet is
fashioned with use of the tubes to provide pressure against the
knot. The hemostat compresses the tube against the arterio-
tomy site by grasping the suture ends, achieving hemostatic
control. The tourniquet is secured for 5 minutes to ensure he-
mostasis. Any anticoagulation, such as heparin, can be reversed
with protamine. Once hemostasis is achieved, the suture ends
are released, the tourniquet is disassembled, and the suture tails
are trimmed close to the arteriotomy.
In the event that bleeding is not controlled by suture,
topical hemostatic agents may be administered into the
Rummel tourniquet. We use thrombin when bleeding con-
tinues despite application of the adjunctive Rummel tourni-
quets. Thrombin is administered by a standard 5-mL syringe
with a large-bore intravenous tip.We inject each of the tubes
with 1 to 2 mL of thrombin. Before the administration of
hemostatic agents into the tube, upward tension on the su-
ture is necessary to ensure maximum apposition of the vessel
walls to avoid injection of thrombin into the vessel. The
tourniquets are then clamped. We allow this column of
topical hemostatic agent to sit over the closure site for
approximately 5 to 10 minutes. The tourniquets are then
removed, and the suture is trimmed in standard fashion.
DISCUSSION
This modiﬁed technique provides secure closure of the
access site after diagnostic and interventional catheterization1693
Fig 1. Intraoperative photograph demonstrating hemostats grasping
free tails of suture from ProGlide device in described method.
Fig 2. Illustration of described “sheath-tourniquet” assembly.
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thrombin, to the puncture site. This novel technique allows
satisfactory hemostasis by combining passive and active
vascular closure methods. The beneﬁts of active closure de-
vices are enhanced by incorporating characteristics of passive
closure, including manual compression and the opportunity
to administer prothrombotic agents directly to the arterio-
tomy site.
This technique requires no materials additional to
those already present in the operating room (introducer
sheath, hemostat) to create a Rummel-style tourniquet.
Traditionally, the Rummel tourniquet is fashioned by pass-
ing an umbilical tape around a vessel and bringing both
ends through a short rubber catheter.3,4 In the modiﬁed
technique described, the suture tails of the ProGlide func-
tion as the constricting portions of the tourniquet as the
tube portion compresses the knot against the arteriotomy
(Fig 2). It can be tightened by the hemostat and also serves
as a conduit for the administration of prothrombotic agents
directly to the site in the event that hemostasis is not
adequately achieved.
We have implemented this technique as part of our
standard practice for all percutaneous endovascular aneu-
rysm repair and thoracic endovascular aortic repair proce-
dures since January 2014. A total of 18 patients have
successfully undergone this modiﬁed percutaneous closure
technique with 100% technical success. No patients have
developed postoperative hematomas, pseudoaneurysms,vessel thrombosis, or other access-related complications.
We use thrombin when bleeding continues despite applica-
tion of the adjunctive Rummel tourniquets.
Before the implementation of this technique, patients
with suboptimal closure who continued to have bleeding
required additional interventions. In most cases, these pa-
tients had up to 30 minutes of bedside manual compression
applied. Of the 22 patients who underwent standard percu-
taneous closure before the use of this technique, three
required immediate open conversion for vascular repair,
two were brought back to the operating room for evacua-
tion of a groin hematoma, and two additional patients
developed a hematoma that was managed conservatively.
The improvement in our results probably reﬂects a learning
curve as well as the addition of the adjunct technique.
CONCLUSIONS
We conclude that hemostasis can be safely achieved by
this adjunctive technique with no signiﬁcant change in
operating time. The instillation of hemostatic agents
directly over the arteriotomy site provides an additional
means of achieving hemostasis.REFERENCES
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